Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

PARP Regulates TGF-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cell Lines

JULIE A. STERLING, LIANG WU and SUNANDITA S. BANERJI
Anticancer Research May 2006, 26 (3A) 1893-1901;
JULIE A. STERLING
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sterlingj{at}uthscsa.edu
LIANG WU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUNANDITA S. BANERJI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Expression of the tumor suppressor gene, transforming growth factor beta receptor type II (TβRII) is often reduced in estrogen receptor-positive breast cancer cells leading to uninhibited tumor cell growth. A clear understanding of its regulation is necessary to identify potential mechanisms to re-express this tumor suppressor gene. Materials and Methods: The regulation of TβRII expression was studied by utilizing 5′ promoter deletion constructs, followed by EMSA analyses. The resulting binding protein was affinity purified and identified by mass spectrophotometry. Results: An inverted CCAAT box centered at -79 was found to be essential for TβRII promoter activity. Purification of the protein binding to this region and subsequent mass spectrophotometric analysis identified the binding protein as poly(ADP-ribose)polymerase I (PARP). ChIP assays verified that PARP interacted with the TβRII promoter in vivo. Conclusion: The present study demonstrated that PARP is important for TβRII expression in estrogen receptor-positive breast cancer cell lines.

  • TGF-beta receptor type II
  • estrogen receptor-positive
  • breast cancer
  • PARP
  • CCAAT box

Footnotes

  • Received March 7, 2006.
  • Accepted March 17, 2006.
  • Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 3A
May-June 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
PARP Regulates TGF-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cell Lines
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
PARP Regulates TGF-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cell Lines
JULIE A. STERLING, LIANG WU, SUNANDITA S. BANERJI
Anticancer Research May 2006, 26 (3A) 1893-1901;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
PARP Regulates TGF-β Receptor Type II Expression in Estrogen Receptor-positive Breast Cancer Cell Lines
JULIE A. STERLING, LIANG WU, SUNANDITA S. BANERJI
Anticancer Research May 2006, 26 (3A) 1893-1901;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Regulation of Bone Morphogenetic Protein Signaling by ADP-ribosylation
  • Transcriptional Roles of PARP1 in Cancer
  • PARP-1 regulates expression of TGF-{beta} receptors in T cells
  • Google Scholar

More in this TOC Section

  • Targeting AURKB Attenuates Tumor Growth in MYC-driven Lung Adenocarcinoma
  • Novel NOTCH1-unmutated T-ALL Cell Line With Suppressed Growth by Gamma-secretase Inhibitors
  • Beneficial Effects of Combining an Immune Checkpoint Inhibitor With Proton Radiation, OXi4503, or Hyperthermia in a Murine Solid Tumor Model
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire